EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAIVE ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 6-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY

被引：1
|
作者：
Correll, Christoph [1 ]
Goldman, Robert [2 ]
Tocco, Michael [2 ]
Pikalov, Andrei [2 ]
Hsu, Jay [2 ]
Loebel, Antony [2 ]
机构：
[1] Hofstra North Shore LIJ Sch Med, Zucker Hillside Hosp, Hempstead, NY USA
[2] Sunovion Pharmaceut Inc, Marlborough, MA USA
来源：
SCHIZOPHRENIA BULLETIN | 2019年 / 45卷
关键词：
D O I：
10.1093/schbul/sbz018.518
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
F106
引用
收藏
页码：S293 / S294
页数：2
相关论文
共 50 条
  • [41] LURASIDONE IN THE TREATMENT OF ACUTE SCHIZOPHRENIA: RESULTS OF THE DOUBLE-BLIND, PLACEBO-CONTROLLED, 6-WEEK, PEARL 3 TRIAL
    Loebel, Antony
    Cucchiaro, Josephine
    Sarma, K.
    Hsu, J.
    Kalali, A. H.
    Potkin, S. G.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 313 - 313
  • [42] Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study
    Iwata, Nakao
    Ishigooka, Jun
    Kim, Won-Hyoung
    Yoon, Bo-Hyun
    Lin, Shih-Ku
    Sulaiman, Ahmad Hatim
    Cosca, Rowena
    Wang, Lina
    Suchkov, Yury
    Agarkov, Alexey
    Watabe, Kei
    Matsui, Tomohito
    Sato, Takayuki
    Inoue, Yoshifumi
    Higuchi, Teruhiko
    Correll, Christoph U.
    Kane, John M.
    SCHIZOPHRENIA RESEARCH, 2020, 215 : 408 - 415
  • [43] The efficacy and safety of lurasidone in adolescent patients with schizophrenia: Results of functional and quality of life measures from a 6-week, double-blind, placebo-controlled study
    Findling, R.
    Goldman, R.
    Cucchiaro, J.
    Deng, L.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2017, 41 : S94 - S94
  • [44] Randomized, double-blind, placebo, and risperidone-controlled study of lurasidone in the treatment of schizophrenia: Results of an inconclusive 6-week trial
    Higuchi, Teruhiko
    Iyo, Masaomi
    Kwon, Jun Soo
    Chou, Yuan-Hwa
    Chen, Hsing-Kang
    Chen, Jen-Yeu
    Chen, Tzu-Ting
    Huang, San-Yuan
    Lee, Jung-Sik
    Saeki, Yuichi
    Tanaka, Hisashi
    Wang, Tzong-Shi
    Wu, Bo-Jian
    Katoh, Takao
    Ishigouoka, Jun
    ASIA-PACIFIC PSYCHIATRY, 2019, 11 (03)
  • [45] Efficacy and Tolerability of Lurasidone in Older Adults with Bipolar Depression: Analysis of Two 6-week Double-blind, Placebo-controlled Studies
    Sajatovic, M.
    Forester, B.
    Tsai, J.
    Kroger, H.
    Pikalov, A.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [46] Frequency, correlates and outcomes of Benzodiazepine use during Cariprazine treatment: A pooled post-hoc analysis from four 6-week, placebo-controlled trials in patients with an acute exacerbation of schizophrenia
    Correll, Christoph U.
    Csehi, Reka
    Acsai, Karoly
    Barabassy, Agota
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2025, 94 : 76 - 83
  • [47] Efficacy and safety of paliperidone extended-release tablets: Results of a 6-week, randomized, placebo-controlled study
    Marder, Stephen R.
    Kramer, Michelle
    Ford, Lisa
    Eerdekens, Els
    Lim, Pilar
    Eerdekens, Marielle
    Lowy, Adam
    BIOLOGICAL PSYCHIATRY, 2007, 62 (12) : 1363 - 1370
  • [48] Efficacy of lurasidone in schizophrenia: Results of a phase 2, placebo-controlled, study
    Phillips, D.
    Ogasa, M.
    Severs, J.
    Nakamura, M.
    Guarino, J.
    Tamura, N.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 572 - 573
  • [49] NABUMETONE THERAPY OF OSTEOARTHRITIS - A 6-WEEK, PLACEBO-CONTROLLED STUDY
    BLECHMAN, WJ
    AMERICAN JOURNAL OF MEDICINE, 1987, 83 (4B): : 70 - 73
  • [50] Recovery in bipolar depression: Post-hoc analysis of a placebo-controlled lurasidone trial followed by a long-term continuation study
    Loebel, Antony
    Siu, Cynthia
    Rajagopalan, Krithika
    Pikalov, Andrei
    Cucchiaro, Josephine
    Ketter, Terence A.
    JOURNAL OF AFFECTIVE DISORDERS, 2015, 186 : 376 - 382
12345